Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2719

Jul 30, 2008

30 days to make antibodies to limit Pandemics

Posted by in categories: biological, biotech/medical, defense, existential risks, lifeboat

Researchers have devised a rapid and efficient method for generating protein sentinels of the immune system, called monoclonal antibodies, which mark and neutralize foreign invaders.

For both ethical and practical reasons, monoclonals are usually made in mice. And that’s a problem, because the human immune system recognizes the mouse proteins as foreign and sometimes attacks them instead. The result can be an allergic reaction, and sometimes even death.

To get around that problem, researchers now “humanize” the antibodies, replacing some or all of mouse-derived pieces with human ones.

Wilson and Ahmed were interested in the immune response to vaccination. Conventional wisdom held that the B-cell response would be dominated by “memory” B cells. But as the study authors monitored individuals vaccinated against influenza, they found that a different population of B cells peaked about one week after vaccination, and then disappeared, before the memory cells kicked in. This population of cells, called antibody-secreting plasma cells (ASCs), is highly enriched for cells that target the vaccine, with vaccine-specific cells accounting for nearly 70 percent of all ASCs.

Continue reading “30 days to make antibodies to limit Pandemics” »

Jul 11, 2008

Metabolomics Could be Part of a BioShield

Posted by in categories: biological, biotech/medical

What is metabolomics?

Genes are similar to the plans for a house; they show what it looks like, but not what people are getting up to inside. One way of getting a snapshot of their lives would be to rummage through their rubbish, and that is pretty much what metabolomics does. […]

Metabolomics studies metabolites, the by-products of the hundreds of thousands of chemical reactions that continuously go on in every cell of the human body. Because blood and urine are packed with these compounds, it should be possible to detect and analyse them. If, say, a tumour was growing somewhere then, long before any existing methods can detect it, the combination of metabolites from the dividing cancer cells will produce a new pattern, different from that seen in healthy tissue. Such metabolic changes could be picked up by computer programs, adapted from those credit-card companies use to detect crime by spotting sudden and unusual spending patterns amid millions of ordinary transactions.

This could be used for traditional medicine, both to prevent pathologies and to detect those that are already present so they can be treated. But another use would be as part of an early-detection system to defend against pandemics and biological attacks. As mentioned previously, network-theory can help us better use vaccines. But once you have a cure or antidote, you also need to identify people that are already infected but haven’t died yet, and the earlier you can do that after the infection, the more chances they have to live.

Continue reading “Metabolomics Could be Part of a BioShield” »

Jul 5, 2008

Using Vaccines more Effectively to Stop Pandemics

Posted by in categories: biological, biotech/medical, information science

If a pandemic strikes and hundreds of millions are at risk, we won’t have enough vaccines for everybody, at least not within the time window where vaccines would help. But a new strategy could help use the vaccines we have more effectively:

Researchers are now proposing a new strategy for targeting shots that could, at least in theory, stop a pandemic from spreading along the network of social interactions. Vaccinating selected people is essentially equivalent to cutting out nodes of the social network. As far as the pandemic is concerned, it’s as if those people no longer exist. The team’s idea is to single out people so that immunizing them breaks up the network into smaller parts of roughly equal sizes. Computer simulations show that this strategy could block a pandemic using 5 to 50 percent fewer doses than existing strategies, the researchers write in an upcoming Physical Review Letters.

vaccine-targeting.jpg

So you break up the general social network into sub-networks, and then you target the most important nodes of these sub-networks and so on until you run out of vaccines. The challenge will be to get good information about social networks, something not quite as easy as mapping computer networks, but there is progress on that front.

Continue reading “Using Vaccines more Effectively to Stop Pandemics” »

Jun 13, 2008

Aging 2008 — an Open Event for Regenerative Medicine

Posted by in category: biotech/medical

There is a strong overlap between those concerned about extinction risk prevention and healthy life extension. Accordingly, many supporters of the Lifeboat Foundation will be attending an open event on regenerative medicine taking place on the UCLA campus on the 27th of June. Here is the blurb:

On Friday, June 27th, leading scientists and thinkers in stem cell research and regenerative medicine will gather in Los Angeles at UCLA for Aging 2008 to explain how their work can combat human aging, and the sociological implications of developing rejuvenation therapies. Aging 2008 is free, with advance registration required.

UCLA Royce Hall
Friday June 27th | Doors open 4pm
405 Hilgard Ave, Los Angeles, CA 90024

This special public event is being organized by the Methuselah Foundation. Dr. Aubrey de Grey, chairman and chief science officer of the Methuselah Foundation, said, “Our organization has raised over $10 million to crack open the logjams in longevity science. With the two-armed strategy of direct investments into key research projects, and a competitive prize to spur on competing scientists’ race to break rejuvenation and longevity records in lab mice, the Foundation is actively accelerating the drive toward a future free of age-related degeneration.” The Methuselah Foundation has been covered by “60 Minutes,” Popular Science, the Wall Street Journal, and other top-flight media outlets.

Continue reading “Aging 2008 -- an Open Event for Regenerative Medicine” »

Jun 11, 2008

Synbioethics/synthethics: Synthetic biology cause concern

Posted by in category: biotech/medical

The report, “Synthetic Biology: Social and Ethical Challenges”, highlights concerns about ownership, misuse, unintended consequences, and accidental release of synthetic organisms into the environment.

Andrew Balmer and Professor Paul Martin, the report’s authors, suggest a threat from “garage biology”, with people experimenting at home. They also emphasise that there is no policy on the impact of synthetic biology on international bioweapons conventions.

Read the entire report here (PDF).

Apr 8, 2008

Disruptions from small recessions to extinctions

Posted by in categories: biotech/medical, business, defense, existential risks, futurism, habitats, lifeboat, nanotechnology, space, sustainability

Cross posted from Next big future by Brian Wang, Lifeboat foundation director of Research

I am presenting disruption events for humans and also for biospheres and planets and where I can correlating them with historical frequency and scale.

There has been previous work on categorizing and classifying extinction events. There is Bostroms paper and there is also the work by Jamais Cascio and Michael Anissimov on classification and identifying risks (presented below).

A recent article discusses the inevtiable “end of societies” (it refers to civilizations but it seems to be referring more to things like the end of the roman empire, which still ends up later with Italy, Austria Hungary etc… emerging)

Continue reading “Disruptions from small recessions to extinctions” »

Mar 8, 2008

Mankind’s secrets kept in lunar ark

Posted by in categories: biotech/medical, defense, space

IF civilisation is wiped out on Earth, salvation may come from space. Plans are being drawn up for a “Doomsday ark” on the moon containing the essentials of life and civilisation, to be activated in the event of earth being devastated by a giant asteroid or nuclear war.

Construction of a lunar information bank, discussed at a conference in Strasbourg last month, would provide survivors on Earth with a remote-access toolkit to rebuild the human race.

A basic version of the ark would contain hard discs holding information such as DNA sequences and instructions for metal smelting or planting crops. It would be buried in a vault just under the lunar surface and transmitters would send the data to heavily protected receivers on earth. If no receivers survived, the ark would continue transmitting the information until new ones could be built.

Continue reading “Mankind's secrets kept in lunar ark” »

Mar 6, 2008

The Global Viral Forecasting Initiative

Posted by in categories: biological, biotech/medical

The Economist has a piece on the Global Viral Forecasting Initiative (GVFI):

Dr [Nathan] Wolfe, [a virologist at the University of California, Los Angeles], is attempting to create what he calls the Global Viral Forecasting Initiative (GVFI). This is still a pilot project, with only half a dozen sites in Africa and Asia. But he hopes, if he can raise the $50m he needs, to build it into a planet-wide network that can forecast epidemics before they happen, and thus let people prepare their defences well in advance. […]

The next stage of the project is to try to gather as complete an inventory as possible of animal viruses, and Dr Wolfe has enlisted his hunters to take blood samples from whatever they catch. He is collaborating with Eric Delwart and Joe DeRisi of the University of California, San Francisco, to screen this blood for unknown viral genes that indicate new species. The GVFI will also look at people, monitoring symptoms of ill health of unknown cause and trying to match these with unusual viruses.

More here. See also the Lifeboat Foundation’s BioShield program.

Feb 23, 2008

New Process Would Turn Greenhouse Gasses into Renewable Fuel Source

Posted by in categories: biotech/medical, chemistry


The New York Times reports
that Jeffrey Martin and William L. Kubic Jr., two scientists from Los Alamos National Laboratories are proposing a process by which the carbon dioxide — the primary greenhouse gas considered responsible for contributing to global warming — emitted from cars and other polluters would be captured and converted to gasoline, methane and jet fuel.

The bold proposal, which the duo have named “Green Freedom” would create a closed cycle from the emission of greenhouse gasses resulting in the creation of a vast source of renewable energy where today we have an open ended cycle that is considered a global threat.

They say the science is relatively simple and straight forward. Polluted air would be blown over potassium carbonate which would sequester the CO2, a chemical process would then remove the trapped CO2 and via a number of established chemical processes it would then be converted to various types of fuel.

Although the process has not been demonstrated and no prototypes have been built the pair claims that the required steps or other chemical processes that they say are close cousins to those required are already in use. In addition, none of the processes violate any known laws of physics and a number of other top researchers have independently made similar suggestions for the sequestration and reuse of emitted CO2.

This concept is not without its share of controversy and detractors however. With claims of everything from the fact that the economics of the process make it unfeasible to concerns that it will encourage further over–population and sprawl not to mention the worry that proliferation of nuclear power brings with it, it is nevertheless an interesting concept and proves — if nothing else — that through continued investment in breakthrough technologies we can overcome all challenges be they environmental or societal.

Jan 28, 2008

Some Progress on Universal Influenza Vaccine

Posted by in categories: biological, biotech/medical

According to ScienceDaily:

The British-American biotech company Acambis reports the successful conclusion of Phase I trials of the universal flu vaccine in humans. The universal influenza vaccine has been pioneered by researchers from VIB and Ghent University. This vaccine is intended to provide protection against all ‘A’ strains of the virus that causes human influenza, including pandemic strains. Therefore, this vaccine will not need to be renewed annually.

InfluenzaWhat would make this new vaccine different from the ones already available is that it would target M2e, a conserved region of influenza “A” strains. Since that part doesn’t constantly mutate and about 2/3 of seasonal epidemics and all pandemics are due to type “A” strains, it could be a very efficient weapon against repeats of the “Spanish Flu” (1918−1919) that killed at least 50 million people worldwide. Only the future will tell if phase II and III trials are successful.

You can learn more about the Lifeboat Foundation BioShield program here.